Oral Diseases · Nov 15, 2026

Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review

By Calderipe CB, Pedroso CM, Lopes MA et al.

Objective: To identify the types of cancer and the corresponding screening methods evaluated in randomized controlled trials (RCTs), with a primary focus on situating oral cancer screening within the RCT‐based body of evidence. Methods: This review followed the PRISMA‐ScR guidelines. PubMed, Web of Science, Embase, Scopus, LILACS, ProQuest, and Google Scholar were searched without date restrictions for studies in English, Spanish, or Portuguese. Eligible studies were RCTs primarily evaluating cancer screening methods (clinical, imaging, endoscopic, laboratory, molecular/serological, or self‐examination). Data were synthesized as means and frequencies. Results: Nine cancer types and 33 distinct screening methods were identified across 97 cancer screenings in 91 RCTs spanning 57 years. Oral cancer ranked last, with only one RCT evaluating a single method, oral visual inspection, the fewest of any cancer type. By comparison, colorectal cancer was the most frequently investigated ( n = 22/22.7%), followed by breast cancer ( n = 21/21.6%) and lung cancer ( n = 18/18.6%), with five, six, and four screening methods evaluated, respectively. Conclusion: These findings map the RCT landscape in cancer screening, revealing marked disparities in evidence across cancer types and identifying oral cancer as the most limited. Further RCTs are urgently needed to strengthen the evidence base and support effective oral cancer screening programs.

doi.org/10.1111/odi.70573Open accessPubMed 43036236Interventions

AgingResearch.News